These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 11354543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytokine blockade in inflammatory bowel diseases.
    Perrier C, Rutgeerts P.
    Immunotherapy; 2011 Nov; 3(11):1341-52. PubMed ID: 22053885
    [Abstract] [Full Text] [Related]

  • 3. Agents against cytokine synthesis or receptors.
    Yamagata T, Ichinose M.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):289-301. PubMed ID: 16457805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of inflammatory cytokine secretion by human alveolar macrophages.
    Losa García JE, Rodríguez FM, Martín de Cabo MR, García Salgado MJ, Losada JP, Villarón LG, López AJ, Arellano JL.
    Mediators Inflamm; 1999 Mar 08; 8(1):43-51. PubMed ID: 10704089
    [Abstract] [Full Text] [Related]

  • 7. Targeting the TNF-alpha pathway in sarcoidosis.
    Antoniu SA.
    Expert Opin Ther Targets; 2010 Jan 08; 14(1):21-9. PubMed ID: 20001207
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytokine blockade as a new strategy to treat rheumatoid arthritis: inhibition of tumor necrosis factor.
    Fox DA.
    Arch Intern Med; 2000 Feb 28; 160(4):437-44. PubMed ID: 10695684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-cytokine vaccination: a new biotherapy of autoimmunity?
    Semerano L, Assier E, Boissier MC.
    Autoimmun Rev; 2012 Sep 28; 11(11):785-6. PubMed ID: 22349621
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
    Theodossiadis PG, Markomichelakis NN, Sfikakis PP.
    Retina; 2007 Sep 28; 27(4):399-413. PubMed ID: 17420690
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B.
    J Rheumatol Suppl; 2005 Mar 28; 74():3-7. PubMed ID: 15742457
    [Abstract] [Full Text] [Related]

  • 16. Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
    Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN.
    Novartis Found Symp; 2004 Mar 28; 256():53-69; discussion 69-73, 106-11, 266-9. PubMed ID: 15027483
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines].
    Stange EF.
    Z Gastroenterol; 2002 Apr 28; 40 Suppl 1():S90-S1. PubMed ID: 11930299
    [Abstract] [Full Text] [Related]

  • 20. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H.
    Z Rheumatol; 1995 Apr 28; 54(3):158-64. PubMed ID: 7660686
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.